| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |